Literature DB >> 33322092

Establishment and Preliminary Characterization of Three Astrocytic Cells Lines Obtained from Primary Rat Astrocytes by Sub-Cloning.

Fabio Caradonna1, Gabriella Schiera1, Carlo Maria Di Liegro1, Vincenzo Vitale1, Ilenia Cruciata1, Tiziana Ferrara1, Pietro D'Oca1, Riccardo Mormino1, Simona Maria Angela Rizzo1, Italia Di Liegro2.   

Abstract

Gliomas are complex and heterogeneous tumors that originate from the glial cells of the brain. The malignant cells undergo deep modifications of their metabolism, and acquire the capacity to invade the brain parenchyma and to induce epigenetic modifications in the other brain cell types. In spite of the efforts made to define the pathology at the molecular level, and to set novel approaches to reach the infiltrating cells, gliomas are still fatal. In order to gain a better knowledge of the cellular events that accompany astrocyte transformation, we developed three increasingly transformed astrocyte cell lines, starting from primary rat cortical astrocytes, and analyzed them at the cytogenetic and epigenetic level. In parallel, we also studied the expression of the differentiation-related H1.0 linker histone variant to evaluate its possible modification in relation with transformation. We found that the most modified astrocytes (A-FC6) have epigenetic and chromosomal alterations typical of cancer, and that the other two clones (A-GS1 and A-VV5) have intermediate properties. Surprisingly, the differentiation-specific somatic histone H1.0 steadily increases from the normal astrocytes to the most transformed ones. As a whole, our results suggest that these three cell lines, together with the starting primary cells, constitute a potential model for studying glioma development.

Entities:  

Keywords:  astrocyte cell lines; astrocytes; epigenetic alterations; gliomas; linker histone H1.0

Year:  2020        PMID: 33322092      PMCID: PMC7764261          DOI: 10.3390/genes11121502

Source DB:  PubMed          Journal:  Genes (Basel)        ISSN: 2073-4425            Impact factor:   4.096


  67 in total

1.  PIPPin is a brain-specific protein that contains a cold-shock domain and binds specifically to H1 degrees and H3.3 mRNAs.

Authors:  T Nastasi; M Scaturro; M Bellafiore; L Raimondi; S Beccari; A Cestelli; I di Liegro
Journal:  J Biol Chem       Date:  1999-08-20       Impact factor: 5.157

Review 2.  Role of H1 linker histones in mammalian development and stem cell differentiation.

Authors:  Chenyi Pan; Yuhong Fan
Journal:  Biochim Biophys Acta       Date:  2015-12-13

3.  Letter to the editor regarding "Proton therapy for low-grade gliomas in adults: A systematic review".

Authors:  Andrea Escobar; Marysabelle Gutierrez; Romina Tejada
Journal:  Clin Neurol Neurosurg       Date:  2020-05-28       Impact factor: 1.876

4.  Cloning and analysis of cDNA for rat histone H1(0).

Authors:  D Castiglia; R Gristina; M Scaturro; I Di Liegro
Journal:  Nucleic Acids Res       Date:  1993-04-11       Impact factor: 16.971

5.  Effect of gene-gene and gene-environment interactions associated with antituberculosis drug-induced hepatotoxicity.

Authors:  Julián G Chamorro; Jorge P Castagnino; Omar Aidar; Rosa M Musella; Ana Frías; Mabel Visca; Mabel Nogueras; Lucas Costa; Alessandro Perez; Fabio Caradonna; Gabriela F de Larrañaga
Journal:  Pharmacogenet Genomics       Date:  2017-10       Impact factor: 2.089

6.  PTHrP in differentiating human mesenchymal stem cells: transcript isoform expression, promoter methylation, and protein accumulation.

Authors:  Alessandra Longo; Mariangela Librizzi; Flores Naselli; Fabio Caradonna; Edda Tobiasch; Claudio Luparello
Journal:  Biochimie       Date:  2013-06-28       Impact factor: 4.079

7.  Synergistic effects of neurons and astrocytes on the differentiation of brain capillary endothelial cells in culture.

Authors:  Gabriella Schiera; Epifania Bono; Maria Pia Raffa; Alessia Gallo; Giovanna Laura Pitarresi; Italia Di Liegro; G Savettieri
Journal:  J Cell Mol Med       Date:  2003 Apr-Jun       Impact factor: 5.310

8.  Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors.

Authors:  Jeanette E Eckel-Passow; Daniel H Lachance; Annette M Molinaro; Kyle M Walsh; Paul A Decker; Hugues Sicotte; Melike Pekmezci; Terri Rice; Matt L Kosel; Ivan V Smirnov; Gobinda Sarkar; Alissa A Caron; Thomas M Kollmeyer; Corinne E Praska; Anisha R Chada; Chandralekha Halder; Helen M Hansen; Lucie S McCoy; Paige M Bracci; Roxanne Marshall; Shichun Zheng; Gerald F Reis; Alexander R Pico; Brian P O'Neill; Jan C Buckner; Caterina Giannini; Jason T Huse; Arie Perry; Tarik Tihan; Mitchell S Berger; Susan M Chang; Michael D Prados; Joseph Wiemels; John K Wiencke; Margaret R Wrensch; Robert B Jenkins
Journal:  N Engl J Med       Date:  2015-06-10       Impact factor: 176.079

9.  2011: the immune hallmarks of cancer.

Authors:  Federica Cavallo; Carla De Giovanni; Patrizia Nanni; Guido Forni; Pier-Luigi Lollini
Journal:  Cancer Immunol Immunother       Date:  2011-01-26       Impact factor: 6.968

10.  The Histone Deacetylase Inhibitor JAHA Down-Regulates pERK and Global DNA Methylation in MDA-MB231 Breast Cancer Cells.

Authors:  Mariangela Librizzi; Roberto Chiarelli; Liana Bosco; Supojjanee Sansook; Jose M Gascon; John Spencer; Fabio Caradonna; Claudio Luparello
Journal:  Materials (Basel)       Date:  2015-10-16       Impact factor: 3.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.